先进制造业知识服务平台
国家科技图书文献中心机械分馆  工信部产业技术基础公共服务平台  国家中小企业公共服务示范平台

OA期刊


ISSN1942-0862
刊名Mabs
出版商Taylor & Francis Inc.
urlhttps://www.tandfonline.com/loi/kmab20
机构Taylor & Francis Ltd.



全部

2010 2011 2012 2013 2014 2015
2016 2017 2018 2019 2020 2021
2022 2023 2024 2025

2017, vol.9, no.1 2017, vol.9, no.2 2017, vol.9, no.3 2017, vol.9, no.4 2017, vol.9, no.5 2017, vol.9, no.6
2017, vol.9, no.7 2017, vol.9, no.8

题名作者出版年年卷期
Novel multispecific heterodimeric antibody format allowing modular assembly of variable domain fragmentsTimothy J. Egan;Dania Diem;Richard Weldon;Tessa Neumann;Sebastian Meyer;David M. Urech;20172017, vol.9, no.1
Rethinking the INN system for therapeutic antibodiesJérémy Pottier;Romane Chastang;Christophe Dumet;Hervé Watier;20172017, vol.9, no.1
Developability of Biotherapeutics: Computational Approaches. Edited by Sandeep Kumar and Satish K. SinghCharlotte M. Deane;Maximiliano Vásquez;20172017, vol.9, no.1
Broad epitope coverage of a human in vitro antibody libraryArvind Sivasubramanian;Patricia Estep;Heather Lynaugh;Yao Yu;Adam Miles;Josh Eckman;Kevin Schutz;Crystal Piffath;Nadthakarn Boland;Rebecca Hurley Niles;Stéphanie Durand;Todd Boland;Maximiliano Vásquez;Yingda Xu;Yasmina Abdiche;20172017, vol.9, no.1
Improving the developability of an anti-EphA2 single-chain variable fragment for nanoparticle targetingMelissa L. Geddie;Neeraj Kohli;Dmitri B. Kirpotin;Maja Razlog;Yang Jiao;Tad Kornaga;Rachel Rennard;Lihui Xu;Birgit Schoerberl;James D. Marks;Daryl C. Drummond;Alexey A. Lugovskoy;20172017, vol.9, no.1
Stability of isolated antibody-antigen complexes as a predictive tool for selecting toxin neutralizing antibodiesPatricia M. Legler;Jaimee R. Compton;Martha L. Hale;George P. Anderson;Mark A. Olson;Charles B. Millard;Ellen R. Goldman;20172017, vol.9, no.1
Systems pharmacology and enhanced pharmacodynamic models for understanding antibody-based drug action and toxicitySihem Ait-Oudhia;Meric Ayse Ovacik;Donald E. Mager;20172017, vol.9, no.1
Note of appreciation to reviewersJanice M. Reichert;20172017, vol.9, no.1
Improved decision making for prioritizing tumor targeting antibodies in human xenografts: Utility of fluorescence imaging to verify tumor target expression, antibody binding and optimization of dosage and application scheduleMichael Dobosz;Ute Haupt;Werner Scheuer;20172017, vol.9, no.1
Demonstration of physicochemical and functional similarity between the proposed biosimilar adalimumab MSB11022 and Humira®Laurent Magnenat;Angelo Palmese;Christèle Fremaux;Fabio D'Amici;Mariagrazia Terlizzese;Mara Rossi;Laurent Chevalet;20172017, vol.9, no.1
12